EET-18042-18360
2 vaccinations
5 coded responses
14 check-ins
5 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 41-45
- ZIP prefix
- 221 / VA
- Registered
- 2021-07-10
- Relationship
- Adult relative or friend
- Guardian
- SPR-16236-24825
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-18
Dose 1 — Pfizer-BioNTech
-
2021-07-09
Dose 2 — Pfizer-BioNTech
-
2021-07-10
Registered in v-safe
-
2021-07-10
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Blood urine present, Dysuria — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Fatigue or tiredness · Be unable to do their normal daily activitiesFree text: Urologic symptoms (difficulty urinating and some drops of blood in urine). Has improved slightly iver course of day after drinking a lot of water.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-11
-
2021-07-12
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Eye inflammation, Eye pain, Self-medication — Feeling: GoodFree text: Mild eye pain/inflammation. Aleve helped.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-13
- 2021-07-14
- 2021-07-15
- 2021-07-16
- 2021-07-30
-
2021-08-08
Survey response — day 28, dose 2, dependentMedDRA: Cough, Influenza, Pyrexia — Feeling: Fair · Be unable to do their normal daily activitiesFree text: Mild flu (fever for 2 days, cough)MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-14
- 2021-08-20
- 2021-10-09
-
2022-01-07
Survey response — 6 months, dose 2, dependentMedDRA: Pneumonitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Lung inflammationMedDRA releases: 2024-11 · check-in free text available
-
2022-01-07
Report sent to call center — 6 months, dose 2, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-01-13
-
2022-01-13
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-07-14
Survey response — 12 months, dose 2, dependentMedDRA: Increased viscosity of upper respiratory secretion, Influenza like illness, Pain, Paranasal sinus hypersecretion, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Flu like illness on 26 June (2 days after my wife). Followed exact same path as wife. 3 days high fever and body aches. After 7 days, only remaining symptom is thick post nasal discharge which has been going on for 2 weeks. No covid test done.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-18 | Pfizer-BioNTech | No |
| 2 | 2021-07-09 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 9 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Urologic symptoms (difficulty urinating and some drops of blood in urine). Has improved slightly iver course of day after drinking a lot of water.
Systemic reaction (other): Mild eye pain/inflammation. Aleve helped.
Release 9 — day 28, dose 2, dependent
Symptoms: Mild flu (fever for 2 days, cough)
Release 10 — 6 months, dose 2, dependent
Symptoms: Lung inflammation
Release 12 — 12 months, dose 2, dependent
Symptoms: Flu like illness on 26 June (2 days after my wife). Followed exact same path as wife. 3 days high fever and body aches. After 7 days, only remaining symptom is thick post nasal discharge which has been going on for 2 weeks. No covid test done.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | · | ✓ |
| SD | Increased viscosity of upper respiratory secretion | · | · | ✓ |
| SD | Influenza | ✓ | · | ✓ |
| SD | Influenza like illness | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Paranasal sinus hypersecretion | · | · | ✓ |
| SD | Pneumonitis | · | · | ✓ |
| SD | Pyrexia | ✓ | · | ✓ |
| SRO | Blood urine present | ✓ | ✓ | ✓ |
| SRO | Dysuria | ✓ | ✓ | ✓ |
| SRO | Eye inflammation | ✓ | ✓ | ✓ |
| SRO | Eye pain | ✓ | ✓ | ✓ |
| SRO | Self-medication | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release